SY

Shanmukhi Yenuganti

Active Director Director DIN 11164131
DIN 11164131 First appointment Jun 2025 Primary industry Ecommerce and Internet
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shanmukhi Yenuganti

Data last updated:

Shanmukhi Yenuganti is a Director at Bookmydoc Healthtech Private Limited (since 2025). The company operates in Ecommerce and Internet.

DIN 11164131
Primary Designation Director
Industry Ecommerce and Internet
First Appointment 20 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bookmydoc Healthtech Private Limited U62012AP2025PTC119926
Director20 Jun 20252025Active

Board colleagues of Shanmukhi Yenuganti

NameDINCompanyDesignation
Vasudev Nayini11164132Bookmydoc Healthtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bookmydoc Healthtech Private Limited
Premium access

Shareholding and investment profile for Shanmukhi Yenuganti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanmukhi Yenuganti

Shanmukhi Yenuganti currently holds 1 directorship: Bookmydoc Healthtech Private Limited (Director, since 20 Jun 2025).

Shanmukhi Yenuganti was first appointed on 20 Jun 2025 as Director at Bookmydoc Healthtech Private Limited.

The current boards of Shanmukhi Yenuganti's companies include Vasudev Nayini (Bookmydoc Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available